Profluent

Profluent is an AI-driven protein design firm founded in 2022 and headquartered in Emeryville, CA. Leveraging deep generative models, the company creates and validates novel, functional proteins that promise to accelerate breakthroughs in biomedicine and gene editing. By marrying cutting-edge machine learning with biological expertise, Profluent offers a unique platform that translates the language of life into tangible therapeutic solutions. Supported by prominent investors such as Spark Capital and Insight Partners, the team is committed to pushing the boundaries of biotechnology while fostering an innovative, collaborative culture.